[Federal Register Volume 76, Number 18 (Thursday, January 27, 2011)]
[Notices]
[Page 4911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-1737]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee:
Times and Dates:
8 a.m.-6 p.m., February 23, 2011.
8 a.m.-5 p.m., February 24, 2011.
Place: CDC, Tom Harkin Global Communications Center, 1600
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines.
Matters To Be Discussed: The agenda will include discussions on:
immunization of healthcare personnel; Japanese encephalitis vaccine;
13-valent pneumococcal conjugate vaccine; human papillomavirus (HPV)
vaccines; human immunodeficiency virus (HIV); hepatitis B vaccine;
pertussis vaccine; influenza; herpes zoster vaccine. Agenda items
are subject to change as priorities dictate.
Contact Person for More Information: Stephanie B. Thomas,
National Center for Immunization and Respiratory Diseases, CDC, 1600
Clifton Road, NE., Mailstop E-05, Atlanta, Georgia 30333, Telephone:
(404) 639-8836, Fax: (404) 639-8905, e-mail [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention,
and the Agency for Toxic Substances and Disease Registry.
Dated: January 20, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-1737 Filed 1-26-11; 8:45 am]
BILLING CODE 4160-18-P